Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-28 LOWE CHRISTOPHER P. COO & Chief Financial Officer Option exercise · Stock Option (right to buy) −20,000 215,594
2021-06-28 McLoughlin Margaret Director Sale −200 $55.01 $11K 350
2021-06-28 McLoughlin Margaret Director Sale −250 $55.03 $14K 100
2021-06-28 McLoughlin Margaret Director Sale −100 $55.73 $6K 0
2021-06-16 Senner Christopher J. Director Grant or award · Stock Option (right to buy) +11,029 11,029
2021-06-16 RYAN UNA S Director Grant or award · Stock Option (right to buy) +11,029 11,029
2021-06-16 McLoughlin Margaret Director Grant or award · Stock Option (right to buy) +11,029 11,029
2021-06-16 Lamond David Director Grant or award · Stock Option (right to buy) +11,029 11,029
2021-05-10 Lynch Casey Chief Executive Officer Sale −13,584 $33.75 $458K 995,190
2021-05-10 Lynch Casey Chief Executive Officer Sale −9,918 $34.89 $346K 985,272
2021-05-10 Lynch Casey Chief Executive Officer Sale −6,315 $35.81 $226K 978,957
2021-05-10 Lynch Casey Chief Executive Officer Sale −183 $36.73 $7K 978,774
2021-03-24 Lamond David Director Purchase +50,000 $33.77 $1.7M 1,847,109
2021-03-22 Lynch Casey Chief Executive Officer Sale −11,211 $35.10 $394K 1,027,563
2021-03-22 Lynch Casey Chief Executive Officer Sale −18,089 $35.85 $648K 1,009,474
2021-03-22 Lynch Casey Chief Executive Officer Sale −300 $36.58 $11K 1,009,174
2021-03-22 Lynch Casey Chief Executive Officer Sale −400 $36.60 $15K 1,008,774
2021-03-04 Lamond David Director Gift +1,534,720 1,534,720
2021-03-04 Lamond David Director Purchase +16,621 $34.28 $570K 1,763,730
2021-03-04 Lamond David Director Purchase +13,310 $35.00 $466K 1,777,040

Page 11 of 18 · 350 trades